Research programme: small molecule G protein coupled receptor modulators - Kainova Therapeutics
Alternative Names: Research programme: small molecule GPCR modulators - Kainova TherapeuticsLatest Information Update: 28 Jun 2026
At a glance
- Originator Domain Therapeutics
- Developer Kainova Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer